Stock Ticker

  • Loading stock data...

Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”

The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]

The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)

The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you don’t solve the healthcare crisis, you can’t solve any of the other crises that have been boiling over in the public discourse. That […]

Gilead Sciences, Inc (NASDAQ:GILD) Speaks Out On The Trial Of Its Remdesivir Drug

Gilead Sciences, Inc (NASDAQ:GILD) is pleased to report about the success it is witnessing with its vaccine Remdesivir. The scientists have been working on the product in the hope that it would turn out to be the vaccine that would possibly help in dealing with COVID-19. Gilead has given an update outlining that it is […]

Gilead Sciences’ (NASDAQ:GILD) Potential COVID-19 Treatment Can Not Undo Damage On The US Economy

Gilead Sciences (NASDAQ:GILD) has a promising COVID-19 cure called remdesivir which caused US equity markets to surge on Friday. However, the surge in the stock market on Friday isn’t something justifiable. Is the economy gearing for fake markets? For stock markets, it has been a gloomy past few weeks and the economy could receive a […]

Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020

Johnson & Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA) in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson & Johnson and BARDA. The first batch of affordable […]

Target Corporation (NYSE:TGT) and Kroger Co (NYSE:KR) Ramp Up Fight Against COVID-19 in Stores

Retail giants Target Corporation (NYSE:TGT) and  Kroger Co (NYSE:KR) are doing everything in their power to maintain operations, even as the Corona pandemic continues to trigger massive shutdown across the U.S. The two retailers have resorted to ingenious ways to try and curb the spread of the coronavirus within their brick and mortar stores. COVID-19 […]

Investing in the Age of Coronavirus (INO, APT, CODX, SGMD, IBIO, AYTU)

The market is crashing almost every day right now. If you own the SPY, or a basket of large-cap leadership stocks that have defined this bull market for years, you’re getting destroyed over the past three weeks. But there is an answer. A small group of stocks has been rallying precisely because of the impact […]

Gilead Sciences Inc. (NASDAQ:GILD) Commences Two Phase 3 Clinical Trials of Remdesivir For COVID-19 Treatment

Gilead Sciences Inc. (NASDAQ:GILD) has announced that it is expanding clinical trials for its antiviral drug remdesivir as a potential treatment of COVID-19 in countries outside China. Gilead to expand clinical trials of remdsivir to other countries outside china The company now expects to begin two new remdesivir clinical trials in March across Asia and […]

Walgreens Boots Alliance (NASDAQ: WBA) To Pay $7.5 Million To Settle Lawsuit Regarding Unlicensed Pharmacist

Walgreens Boots Alliance (NASDAQ:WBA) has agreed to settle a consumer protection lawsuit by paying $7.5 million after Alameda County District Attorney claimed that one of Walgreens ’pharmacists had worked in the Bay Area over a decade without a license. Walgreens pharmacist handled 745,000 prescriptions without a license. Prosecutors indicated that Kim Thien Le had handled […]

Myriad Genetics (NASDAQ:MYGN) Shares Stop Bleeding on Positive Study of Prenatal Genetics Test

It’s certainly been a white-knuckle ride in 2019 for shareholders of the molecular diagnostics and precision medicines company Myriad Genetics (NASDAQ: MYGN), with shares doubling and getting halved over a few weeks this summer. A slow climb starting in June from $22 culminated with a 55% explosion on August 1-2 to $48 thanks to news […]

Innovators in the Booming Pharmacy Services Space (WBA, RXMD, CERN, MDRX, CVS)

The market is ripping higher. But one of the most important leadership areas isn’t what most retail investors generally think about when they think of big capital gains growth. The pharmacy services space is the focus here. It’s a staple. Demand is inelastic within the context of the market cycle – these stocks generally won’t […]

Sanofi SA (NASDAQ:SNY) Would Focus On Cancer Treatments For Rapid Growth: Sanofi In Advanced Stage To Divest Seprafilm

Sanofi SA (NASDAQ:SNY) is in advanced talks to divest Seprafilm to Baxter International Inc (NYSE:BAX). Seprafilm is valued at up to $400 million. It is used to eliminate scars resulting from pelvic and abdominal surgeries. Sanofi intends to focus on cancer treatments to achieve rapid growth. Products to reduce complications Baxter is engaged in the […]

CVS Health Corp (NYSE:CVS) Suspends Sale of Zantac Over Cancer Concerns

CVS Health Corp (NYSE:CVS) has announced that will no longer sell heartburn drug Zantac which the FDA is investigating for links to cancer. The company announced on Saturday that it was suspending over-the-counter sales of the drug as a caution. Zantac could have cancer casing carcinogen The move comes after concerns from several countries about […]

Amgen Inc. (NASDAQ:AMGN) Announces The Purchase of Immunology Drug Otezla from Celgene Corporation (NASDAQ:CELG)

Amgen Inc. (NASDAQ:AMGN) has announced the purchase of Celgene Corporation’s (NASDAQ:CELG) leading immunology drug Otezla for around $13.4 billion. Otezla purchase deal to be finalized at the end of the year The company has indicated that the deal will be closed at the end of the year. Following the announcement, Amgen’s stock gained 2.85% to […]

Sign Up To Get Our Latest Stocks Alerts